Therapeutic nuclear magnetic resonance system benches are an innovative technology used for pain management and tissue healing. Utilizing a weak magnetic field with radio frequency pulses to disorient hydrogen nuclei in cells and tissues and release their energy as they return to their original states, therapeutic results may result.
Treatment of Osteoarthritis
Nuclear Magnetic Resonance Therapy is a noninvasive medical procedure based on the principles of magnetic resonance imaging (MRI), but with significantly weaker magnets and radio waves. It operates using a magnetic field which causes hydrogen protons to oscillate within irradiated tissues to emit energy that can be used to visualize internal structures like tissues, organs and bone – but also be transferred directly to cells that have become inflamed, injured or degenerated to stimulate molecular level regeneration, leading to improved mobility and pain relief.
Studies on the treatment of osteoarthritis have demonstrated that five sessions of one hour each for five days of NMRT significantly reduce pain, function and quality of life due to stimulating natural repair mechanisms and stimulating immunity systems. For the first time ever, an effective method for direct energy transfer from cell to cell has been created and proven clinically.
This therapeutic approach serves as a great supplement to conventional orthopaedic treatments and, particularly pharmacological therapy. Long term medication use may increase fracture risk; thus this alternative to medication therapy becomes all the more appealing.
Studies have demonstrated that one hour of NMRT therapy can significantly alleviate symptoms associated with knee osteoarthritis. Patients can now perform daily activities without difficulty; before therapy began, tasks like walking and personal care (washing, dressing and undressing) were either challenging for them or required considerable effort; often this required them to make lifestyle adjustments or seek assistance for certain tasks.
Researchers have noted that decreased inflammation caused by osteoarthritis (OA) leads to thickening cartilage thickness; this can be observed through MRI imaging where darkened spots indicate damaged areas compared with healthy cartilage.
Treatment of Rheumatoid Arthritis
Treating rheumatoid arthritis (RA) requires both symptomatic and pharmacological therapies. The main goal of pharmacological therapies is to decrease inflammation and thus slow or stop its progression of joint damage as well as cartilage and bone degeneration. Recently, various imaging technologies such as magnetic resonance imaging with hyperpolarized carbon-13 compounds, dual PET/MRI scanners and magnetic resonance imaging with iron-based particles have been developed to assist physicians in pinpointing areas of inflammation, signal severity of disease severity and assess treatment response.
However, these imaging strategies are limited by their low sensitivity and often take an inordinately long amount of time to perform. Furthermore, they don’t provide information about active inflammatory cells’ metabolism.
NMR therapy provides the solution. Nuclear magnetic resonance imaging can detect and quantify disease-causing molecules present in tissue without having to resort to invasive surgery techniques like PET.
NMR imaging involves producing magnetic fields by vibrating hydrogen atoms present in water samples. Unlike its conventional X-ray counterpart, NMR does not emit radiation and poses no health risks associated with its use.
NMR provides us with a unique view into the interior of our bodies like never before possible, providing insight into conditions like osteoarthritis, rheumatoid arthritis, back pain and other disorders. NMR therapy has now been successfully used to treat diseases like these as well as conditions like back pain.
One promising approach for treating RA with NMR is targeting macrophages – pro-inflammatory cells found in arthritis joints that produce pro-inflammatory cytokines – via NMR. They overexpress folate receptors which can be targeted using nanoparticles functionalized with folic acid–these have been found to bind activated macrophages and accumulate in affected tissues.
This study conducted by its authors involved an examination of serum samples from 38 early RA patients at baseline and after 24 weeks of treatment with methotrexate (MTX). Metabolomics data was then examined using 1H NMR spectroscopy with a 600 M instrument; dynamic NMR metabolomics proved its usefulness for RA patients by showing positive correlations with Paulus criteria while negative ones existed with ESR and CRP levels.
Treatment of Osteoporosis
Osteoporosis is a condition affecting bone health caused by bone mass loss and fractures, most often seen among females. Osteoporosis occurs most commonly among women and causes more deceases among them than any of the most prevalent cancers (breast, uterine and ovarian cancers) combined.
Osteoporosis is caused by disruptions to normal metabolic processes of bone metabolism, leading to reduced bone density and an increase in fracture risk, along with back pain and discomfort. Treatment typically includes various measures including medications.
Nuclear magnetic resonance therapy has an enormously positive impact on patients suffering from osteoporosis. This therapy’s success lies in its ability to alter electron radical pair dynamics within mitochondria cells – responsible for producing energy that is vital for cell functions – NMRT can increase production while simultaneously improving metabolism, leading to improved health benefits and bone regeneration for its patients.
Measures of NMRT effectiveness can be determined through measurement of parameters such as bone mineral density, serum levels of osteocalcin and crosslinked degradation products of collagen that act as indicators for bone turnover. A DEXA device can help measure these indicators. Any changes can be identified by comparing them against baseline values recorded at the start of an NMR therapy block consisting of one hour sessions; an increase in BMD as well as increases in osteocalcin and bCTX can be observed following each NMR session block.
NMRT produces a weak magnetic field that is 10,000 times weaker than diagnostic MRI and does not produce any harmful side effects or interfere with other medical devices. It has proven extremely successful as an adjunctive treatment option for degenerate muscular conditions that cause pain. Clinics and rehabilitation facilities worldwide utilize this technology.
Treatment of Back Pain
Even with advances in orthopaedics and physical therapy, chronic musculoskeletal conditions like osteoarthritis, osteoporosis and back pain remain challenging to treat due to a lack of effective methods which accelerate tissue regeneration while attenuating pain symptoms.
Therapeutic nuclear magnetic resonance system benches offer promising solutions in pain management and tissue healing. Their multi-patented technology communicates directly with damaged and degenerated cartilage, bone, ligament, tendon and muscle cells to encourage their repair and regrow – effectively relieving pain faster while speeding recovery from conditions such as arthritis, osteoporosis or chronic back pain.
Since 2007, MBST has been used successfully to treat musculoskeletal diseases in Germany, Austria, Turkey, England and Czech Republic – as evidenced by one year follow up data of more than 4,500 patients suffering from degenerative rheumatic diseases that were successfully treated using this therapy.
Chronic low back pain treatment usually begins with spinal manipulations and manual therapy. If necessary, Sinuvertebral Blockade from Diprophos or Lignocaine may be applied as well. As part of later stages, damaged intervertebral discs will often require treatment using both MBST(r) and DiscoGel(r).
During therapy, magnetic fields influence hydrogen nuclei (protons) present in human body tissues to align in an identical fashion, producing energy which is harnessed by a therapeutic nuclear magnetic resonance device. As protons return to their original positions, they release more energy that stimulates cell repair and revitalizes cartilage. Furthermore, this activating energy activates production of cytokines which help reduce inflammation while speeding up growth of new cartilage and bone. After only one treatment, patients experienced significant relief of pain. Pain symptoms assessed via VAS and functional scale according to the Revised Oswestry Low Back Pain Disability Scale were markedly reduced six weeks following NMR therapy for all patient groups studied, remaining measurably reduced up to one year post treatment. Furthermore, intensity reduction occurred for pain on load, movement pain and restful discomfort all increased significantly with treatment by NMR therapy.
